Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
Revenues | 65.4 | 34.1 | 21.1 | -0.6 | 0.0 |
Revenue growth | 91.7% | 61.3% | -3869.4% | | |
Cost of goods sold | 35.8 | 34.7 | 23.9 | -0.3 | 0.0 |
Gross profit | 29.5 | -0.7 | -2.7 | -0.3 | 0.0 |
Gross margin | 45.2% | -1.9% | -12.9% | 47.1% | |
Selling, general and administrative | 79.7 | 86.7 | 28.6 | 0.0 | 0.0 |
Research and development | 0.7 | 0.1 | 0.3 | | |
EBITA | -83.9 | -99.3 | -40.9 | -0.3 | 0.0 |
EBITA margin | -128.3% | -291.4% | -193.7% | 47.1% | |
Amortization of intangibles | 0.6 | 1.4 | 1.4 | | |
EBIT | -84.5 | -100.7 | -42.3 | -0.3 | 0.0 |
EBIT margin | -129.2% | -295.5% | -200.4% | 47.1% | |
Pre-tax income | -74.9 | -244.0 | -47.7 | -7.1 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | | 0.0% |
Net income | -74.2 | -245.6 | -19.5 | -7.2 | 0.0 |
Net margin | -113.5% | -720.7% | -92.4% | 1285.8% | |
|
Diluted EPS | ($0.64) | ($3.37) | ($1.45) | ($0.92) | $0.00 |
Shares outstanding (diluted) | 117.8 | 72.5 | 33.0 | 7.8 | 8.3 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|